Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harriet Richardson

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Frontiers in Oncology|July 5, 2016
Polymorphisms of Insulin-Like Growth Factor 1 Pathway Genes and Breast Cancer RiskJoy Shi, Kristan J Aronson, Anne Grundy, et al.
Current Oncology (Toronto, Ont.)|January 27, 2026
The CAnadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT): A Multi-Phase Program OverviewLinda E Carlson, Harriet Richardson, Ron Shore, et al.
The Lancet. Oncology|February 10, 2012
Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trialAngela M Cheung, Lianne Tile, Savannah Cardew, et al.
European Journal of Haematology|May 30, 2021
A descriptive cost-analysis of MYX.1/MCRN003, a phase 2 clinical trial evaluating high-dose weekly carfilzomib, cyclophosphamide, and dexamethasone in relapsed and refractory multiple myelomaBethany E Monteith, Christopher P Venner, Matthew C Cheung, et al.
The New England Journal of Medicine|June 7, 2011
Exemestane for breast-cancer prevention in postmenopausal womenPaul E Goss, James N Ingle, José E Alés-Martínez, et al.
The Journal of Clinical Endocrinology and Metabolism|May 12, 2026
Establishment of harmonized international reference ranges for plasma estradiol concentrations in postmenopausal womenJinghan Cui, Susan E Hankinson, Alvin M Matsumoto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 9, 2014
Quality of life in MAP.3 (Mammary Prevention 3): a randomized, placebo-controlled trial evaluating exemestane for prevention of breast cancerElizabeth Maunsell, Paul E Goss, Rowan T Chlebowski, et al.
Journal of Virology|April 18, 2014
Global genomic diversity of human papillomavirus 6 based on 724 isolates and 190 complete genome sequencesMateja M Jelen, Zigui Chen, Boštjan J Kocjan, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Frontiers in Oncology|July 5, 2016
Polymorphisms of Insulin-Like Growth Factor 1 Pathway Genes and Breast Cancer RiskJoy Shi, Kristan J Aronson, Anne Grundy, et al.
Current Oncology (Toronto, Ont.)|January 27, 2026
The CAnadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT): A Multi-Phase Program OverviewLinda E Carlson, Harriet Richardson, Ron Shore, et al.
The Lancet. Oncology|February 10, 2012
Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trialAngela M Cheung, Lianne Tile, Savannah Cardew, et al.
European Journal of Haematology|May 30, 2021
A descriptive cost-analysis of MYX.1/MCRN003, a phase 2 clinical trial evaluating high-dose weekly carfilzomib, cyclophosphamide, and dexamethasone in relapsed and refractory multiple myelomaBethany E Monteith, Christopher P Venner, Matthew C Cheung, et al.
The New England Journal of Medicine|June 7, 2011
Exemestane for breast-cancer prevention in postmenopausal womenPaul E Goss, James N Ingle, José E Alés-Martínez, et al.
The Journal of Clinical Endocrinology and Metabolism|May 12, 2026
Establishment of harmonized international reference ranges for plasma estradiol concentrations in postmenopausal womenJinghan Cui, Susan E Hankinson, Alvin M Matsumoto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 9, 2014
Quality of life in MAP.3 (Mammary Prevention 3): a randomized, placebo-controlled trial evaluating exemestane for prevention of breast cancerElizabeth Maunsell, Paul E Goss, Rowan T Chlebowski, et al.
Journal of Virology|April 18, 2014
Global genomic diversity of human papillomavirus 6 based on 724 isolates and 190 complete genome sequencesMateja M Jelen, Zigui Chen, Boštjan J Kocjan, et al.
Pageof 6